|
Mr. Kania is Managing Partner and Chairman of Flagship Ventures. Prior to co-founding Flagship Ventures in 1999, he spent 15 years as Managing General Partner of OneLiberty Ventures and as General Partner at its predecessor firm, Morgan Holland Ventures. His direct investment experience covers over 100 companies. In addition, he has been intimately involved in the launch and development of more than a dozen companies as the founding and lead investor. Mr. Kania is currently a director of Aspect Medical Systems (NASDAQ: ASPM), EXACT Sciences (NASDAQ: EXAS), Abla-Tx, Acceleron Pharma, Interactive Supercomputing Corporation, Nanostream, Inc., and Pervasis Therapeutics. Mr. Kania also serves as Chairman of the Board of TransMedics and VisEn Medical. He is also a director of the Massachusetts Biotechnology Council. Mr. Kania holds a degree in physics from Dartmouth College and an MBA from the Harvard Business School. | 